EQUIBOR
Turnover is estimated at about €190,000, probably between €130,000 and €340,000. The micro format does not state turnover.
Balance sheet
balance sheet total €1.1m on 31-12-2025in euro
in euro
Position in the sector
24.7%
Higher than 44% of the 89 companies filing micro accounts in pharmaceuticals (NACE 21) in 2025.
2.4%
Higher than 51% of the 84 companies filing micro accounts in pharmaceuticals (NACE 21) in 2025.
Net result: middle half · Equity: top quarter · Balance sheet total: top quarter
Key figures and ratios
per financial year, computed from the annual accounts| Line | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 201914 months |
|---|---|---|---|---|---|---|---|---|
| 0 | 20,894 | 4,468 | 890,238 | 578 | 8,087 | 15,059 | ||
| 51,735 | -2,382 | -315,132 | 269,540 | 365 | 21,660 | - | ||
| 24.7% | 22.2% | 19.2% | -4.3% | 20.1% | 22.6% | 23.8% | ||
| 9.7% | 14.5% | 20.2% | - | -30.7% | 30.9% | 46.8% | ||
| 2.4% | 3.2% | 3.9% | -5.3% | -6.2% | 7.0% | 11.1% |
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
Filed annual accounts
as filed with the National Bank, click a year to choose it| Line | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 201914 months |
|---|---|---|---|---|---|---|---|---|
| Balance sheet: assets | ||||||||
20/58 |
1.1m | 1.1m | 1.1m | 1.3m | 63,998 | 74,425 | 48,965 | |
21/28 |
899,059 | 907,513 | 896,693 | 896,824 | 10,454 | 14,538 | 9,875 | |
22/27 |
8,821 | 17,275 | 6,455 | 6,586 | 10,454 | 14,538 | 9,875 | |
23 |
490 | 849 | 132 | 324 | - | 578 | 1,348 | |
24 |
8,331 | 16,426 | 6,323 | 4,718 | 6,852 | 8,299 | 808 | |
26 |
- | - | - | 1,544 | 3,603 | 5,661 | 7,720 | |
28 |
890,238 | 890,238 | 890,238 | 890,238 | - | - | - | |
29/58 |
221,717 | 217,503 | 211,622 | 371,344 | 53,544 | 59,887 | 39,089 | |
40/41 |
166,184 | 213,624 | 205,545 | 49,981 | 1,748 | 8,462 | 9,056 | |
40 |
78,800 | 60,500 | 37,244 | - | 318 | 8,197 | 6,930 | |
41 |
87,384 | 153,124 | 168,301 | 49,981 | 1,430 | 264 | 2,127 | |
54/58 |
55,269 | 3,534 | 5,916 | 321,048 | 51,508 | 51,143 | 29,483 | |
490/1 |
263 | 346 | 162 | 316 | 288 | 283 | 550 | |
| Balance sheet: equity and liabilities | ||||||||
10/49 |
1.1m | 1.1m | 1.1m | 1.3m | 63,998 | 74,425 | 48,965 | |
10/15 |
276,355 | 249,420 | 213,329 | -54,826 | 12,895 | 16,848 | 11,648 | |
10/11 |
231,200 | 231,200 | 231,200 | 6,200 | 6,200 | 6,200 | 6,200 | |
100 |
- | - | - | - | - | - | 18,550 | |
101 |
- | - | - | - | - | - | 12,350 | |
13 |
111,680 | 84,746 | 48,655 | 5,500 | 5,500 | 5,500 | 300 | |
130/1 |
- | 300 | 300 | 300 | 300 | 300 | - | |
130 |
- | - | - | - | - | - | 300 | |
1311 |
- | 300 | 300 | 300 | 300 | 300 | - | |
133 |
111,680 | 84,446 | 48,355 | 5,200 | 5,200 | 5,200 | - | |
14 |
-66,525 | -66,525 | -66,525 | -66,525 | 1,195 | 5,148 | 5,148 | |
17/49 |
844,421 | 875,596 | 894,986 | 1.3m | 51,103 | 57,577 | 37,316 | |
17 |
196,050 | 238,487 | 279,276 | - | - | - | - | |
170/4 |
196,050 | 238,487 | 279,276 | - | - | - | - | |
42/48 |
648,371 | 637,109 | 615,710 | 1.3m | 51,103 | 57,577 | 37,316 | |
42 |
42,436 | 40,790 | 39,183 | - | - | - | - | |
44 |
6,041 | 2,769 | 2,539 | 1,264 | - | 245 | 744 | |
440/4 |
6,041 | 2,769 | 2,539 | 1,264 | - | 245 | 744 | |
45 |
11,580 | 10,460 | 5,621 | 229 | 6,004 | 8,323 | 3,889 | |
450/3 |
11,580 | 10,460 | 5,621 | 229 | 6,004 | 8,323 | 3,889 | |
47/48 |
588,313 | 583,091 | 568,367 | 1.3m | 45,099 | 49,009 | 32,683 | |
| Income statement | ||||||||
76A |
- | 4,113 | - | - | - | - | - | |
9900 |
65,357 | 76,356 | 67,436 | -63,668 | 1,581 | 11,028 | 13,701 | |
630 |
8,454 | 8,187 | 4,598 | 3,869 | 4,661 | 3,425 | 5,184 | |
640/8 |
326 | 63 | 684 | - | 719 | 45 | 351 | |
9901 |
56,578 | 68,106 | 62,153 | -67,537 | -3,800 | 7,558 | 8,167 | |
75/76B |
- | - | 0 | 12 | - | 20 | 4 | |
75 |
- | - | 0 | 12 | - | 20 | 4 | |
65/66B |
15,553 | 17,157 | 18,850 | 76 | 44 | - | 38 | |
65 |
15,553 | 17,157 | 18,850 | 76 | 44 | - | 38 | |
9903 |
41,025 | 50,948 | 43,303 | -67,601 | -3,843 | 7,578 | 8,133 | |
67/77 |
14,091 | 14,857 | 148 | 120 | 110 | 2,378 | 2,685 | |
9904 |
26,934 | 36,091 | 43,155 | -67,721 | -3,953 | 5,200 | 5,448 | |
9905 |
26,934 | 36,091 | 43,155 | -67,721 | -3,953 | 5,200 | 5,448 | |
| Appropriation of the result | ||||||||
9906 |
-39,591 | -30,434 | -23,371 | -66,525 | 1,195 | 10,348 | 5,448 | |
14P |
-66,525 | -66,525 | -66,525 | 1,195 | 5,148 | - | - | |
691/2 |
26,934 | 36,091 | 43,155 | - | - | 5,200 | 300 | |
6920 |
- | - | - | - | - | - | 300 | |
6921 |
26,934 | 36,091 | 43,155 | - | - | 5,200 | - | |
| Document | ||||||||
The full notes are in the accounts filed with the NBB.
Source: Annual accounts 2025 at the NBB, filed on 25-06-2026.
Filings
each dot is a set of accounts, on the day it reached the National Bank| Financial year | Type | Filed | Reference | Document |
|---|---|---|---|---|
| 31-12-2025 | micro format | 25-06-2026 | 2026-00206217 | |
| 31-12-2024 | micro format | 28-07-2025 | 2025-00333566 | |
| 31-12-2023 | micro format | 05-08-2024 | 2024-00332173 | |
| 31-12-2022 | micro format | 16-06-2023 | 2023-00137568 | |
| 31-12-2021 | micro format | 08-07-2022 | 2022-20162169 | |
| 31-12-2020 | micro format | 31-08-2021 | 2021-61100505 | |
| 31-12-2019 | micro format | 31-08-2020 | 2020-48000519 |
Subsidies and aid
Flemish government 2022, 1 entry, €416 awarded, €416 paid
Investments
fixed assets acquired| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tangible fixed assets | - | €20,894 | €4,468 | - | €578 |
| Financial fixed assets | - | - | - | €890,238 | - |
| €8,454 | €8,187 | €4,598 | €3,869 | €4,661 |
Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)
Insights on EQUIBOR
The operating result for 2025 is 17% lower than in 2024 and the lowest since 2022.
Debt's share of the balance-sheet total falls from 77.8% to 75.3%. Equity is higher and debt is lower.